The enterprise specializes in the production of antitumor drugs in parenteral sterile forms. The launch of production will meet the needs of Belarus for a number of antitumor drugs. The company plans to produce azacitidine, cabazitaxel, pemetrexed, carfilzomib, etc. The list of products will be constantly expanding.
The main task of Onco Solutions LLC is to produce drugs for the treatment of oncological diseases that are in demand in Belarus, Russia, Kazakhstan, Armenia, and the Kyrgyz Republic. The production is planned for export to the countries of the Eurasian Economic Union, near and far abroad, and for import substitution purposes. The share of export deliveries after the launch of production will be 80%.
The production capacity allows for the production of 500,000 bottles of finished products annually. The total investment costs for the project amounted to more than 50 million Belarusian rubles, and more than 35 new jobs have been created to date.
